C07D495/00

Pyrimidine based modulators and uses thereof

Provided herein are compounds, such as compounds of Formula (I), Formula (I-A), Formula (I-B), or pharmaceutically acceptable salts of any one there, useful for modulating KRAS GD12 and/or other G12 mutants.

Organic electroluminescent compound, a plurality of host materials and organic electroluminescent device comprising the same

The present disclosure relates to an organic electroluminescent compound represented by formula 2 or formula 2, a plurality of host materials comprising at least one first host compound and at least one second host compound, and an organic electroluminescent device comprising the same. An organic electroluminescent device having improved driving voltage, luminous efficiency, power efficiency and/or lifespan properties can be provided by including the organic electroluminescent compound or a specific combination of compounds according to the present disclosure as a host material(s).

Organic electroluminescent compound, a plurality of host materials and organic electroluminescent device comprising the same

The present disclosure relates to an organic electroluminescent compound represented by formula 2 or formula 2, a plurality of host materials comprising at least one first host compound and at least one second host compound, and an organic electroluminescent device comprising the same. An organic electroluminescent device having improved driving voltage, luminous efficiency, power efficiency and/or lifespan properties can be provided by including the organic electroluminescent compound or a specific combination of compounds according to the present disclosure as a host material(s).

Compound as WNT signaling inhibitor, composition, and use thereof
09556144 · 2017-01-31 · ·

The present invention relates to a compound having the structure of Formula I as inhibitor of WNT signal transduction pathways, as well as a composition comprising the compound. Further, the present invention relates to the use of the compound and the method of inhibiting the WNT signal transduction pathways. ##STR00001##

Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections

This invention relates to thieno[3,2-d]pyrimidines derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.

Materials for electronic devices

The present application relates to materials for use in electronic devices, to processes for preparing the materials, and to electronic devices containing the materials.

Materials for electronic devices

The present application relates to materials for use in electronic devices, to processes for preparing the materials, and to electronic devices containing the materials.

HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC MATERIAL LAYER FORMATION COMPOSITION WHICH COMPRISE SAME

The present specification relates to a heterocyclic compound of Chemical Formula 1, an organic light emitting device including the same and a composition for forming an organic material layer.

HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC MATERIAL LAYER FORMATION COMPOSITION WHICH COMPRISE SAME

The present specification relates to a heterocyclic compound of Chemical Formula 1, an organic light emitting device including the same and a composition for forming an organic material layer.

MATERIALS FOR ELECTRONIC DEVICES

The present application relates to materials for use in electronic devices, to processes for preparing the materials, and to electronic devices containing the materials.